Testing effectiveness (Phase 2)Study completedNCT06162728
What this trial is testing
Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)
Who this might be right for
Chronic Spontaneous Urticaria
Jasper Therapeutics, Inc. 87